ViraPower™ Lentiviral Directional TOPO™ Expression Kit
Product Image
Invitrogen™

ViraPower™ Lentiviral Directional TOPO™ Expression Kit

The ViraPower™ Lentiviral Directional TOPO™ Expression Kit includes all the components needed to generate lentivirus, including vector kit, 293FT cellRead more
Catalog NumberQuantity
K4950001 kit
Catalog number K495000
Price (JPY)
586,100
Each
Contact Us ›
Quantity:
1 kit
The ViraPower™ Lentiviral Directional TOPO™ Expression Kit includes all the components needed to generate lentivirus, including vector kit, 293FT cell line, and the support kit. It combines Invitrogen’s ViraPower™ Lentiviral and Directional TOPO™ technologies to facilitate quick PCR-based cloning and lentiviral-based expression of a target gene in dividing and non-dividing mammalian cells. The pLenti6⁄V5-D-TOPO™ vector has the CMV promoter for driving constitutive expression of the target gene and the blasticidin selection marker for stable selection in mammalian cells.

Advantages
• Lentivirus based expression of a target gene in dividing and non-dividing mammalian cells

Key Features
• Quick convenient Directional TOPO™ cloning technology
• Constitutive high expression with CMV promoter
• Blasticidin selection marker for stable selection
• C terminal V5 tag for quick detection

Kit includes
• pLenti6⁄V5-D™-TOPO™ vector
• ViraPower™ Bsd Lentiviral Support Kit (K4970-00)
• 293FT Cell Line (R70007)
• One Shot™ Stbl3™ Chemically Competent E. coli (C7373-03)

Related SKUs
• pLenti6⁄V5™ Directional TOPO™ Cloning Kit (K4955-10)
• ViraPower™ Lentiviral Gateway™ Expression Kit (K4960-00)
• ViraPower™ HiPerform™ Lentiviral TOPO™ Expression Kit (K5310-00)
• pLenti6.3?V5™-TOPO™ TA Cloning™ Kit (K531520)

For research use only. Not intended for any therapeutic or diagnostic use.
For Research Use Only. Not for use in diagnostic procedures.
Specifications
Constitutive or Inducible SystemConstitutive
Delivery TypeLentiviral
For Use With (Application)Viral Expression
Product TypeLentiviral Expression Kit
Quantity1 kit
Selection Agent (Eukaryotic)Blasticidin
VectorDirectional TOPO Vectors
Cloning MethodDirectional TOPO
Product LineOne Shot
PromoterCMV
Protein TagV5 Epitope Tag
Unit SizeEach
Contents & Storage
pLenti6⁄V5™ Directional TOPO™ Cloning Kit:
• pLenti6⁄V5™ Directional TOPO™ Reagents: -20°C
• One Shot™ Stbl3™ Chemically Competent E. coli:-80°C

ViraPower™ Bsd Lentiviral Support Kit:
• ViraPower™ Packaging Mix: -20°C
• Lipofectamine™ 2000: 4°C (DO NOT freeze)
• Blasticidin: -20°C
• 293FT Cell Line: liquid nitrogen

Frequently asked questions (FAQs)

I used one of your lentiviral vectors but am observing cytotoxic effects after transduction. Can you please help?

Possible causes include:

- large volume of viral supernatant used for transduction
- cells sensitive to Polybrene regaent
- too much antibiotic used for selection
- antibiotic used too soon after tranduction
- gene of interest is toxic to cells

I transduced my lentiviral stock into my mammalian cell line but am getting poor expression of my gene of interest. What could have happened?

Poor expression could result from low transduction efficiency, too low of a MOI, too much antibiotic used for selection, usage of antibiotic too soon after transduction, harveting cells too soon after transduction, having a gene of interest that is toxic to cells, or rerrangement in the LTR regions of the expression construct plasmid DNA.

I transduced my lentiviral stock into my mammalian cell line but am getting no expression of my gene of interest. What could have gone wrong?

Here are some possible causes and solutions:
- Promoter silencing; CMV promoter is prone to silencing especially in mouse and rat cells, screen multiple antibiotic resistant clones and select the one with the highest expression levels
- Viral stocks stored incorrectly; aliquot and store at -80 degrees C, do not freeze/thaw more than 3 times

I prepared a lentiviral stock using one of your lentiviral vectors. I am trying to determine the titer using antibiotic selection but am not able to since the cells are very confluent and I am not getting antibiotic-resistant clones. Can you please offer some tips?

Here are some possible causes and solutions:

- Too little antibotic used for selection
- Selection performed on confluent cells; replate cells
- Viral supernatant not diluted sufficiently; titer lentivus using a wider range of 10-fold serial dilutions

I am using one of your lentiviral vectors and am getting a low lentiviral titer. Can you offer some troubleshooting tips?

Possible causes include:

- low transfection efficiency; Use a high-quality plasmid prep, 293FT cells under passage 16, ensure removal of Geneticin during transfection, ensure correct DNA:lipid ratio, and that cells are plated at the correct confluency
- transfected cells are not cultured in medium containing sodium pyruvate; this reagent provides an extra energy source for cells
- viral supernatant harvested too early; viral supernatants can generally be collected 48-72 hrs post-transfection
- viral supernatant too dilute; concentrate virus using CsCl purification
- viral supernatant frozen and thawed multiple times; 3 times should be the maximum freeze/thaw
- gene of interest is large; viral titers decrease as size of insert increases, inserts larger than 5.6 kb are not recommended
- rearrangement in the LTR region of the epxression construct plasmid DNA; use Stb3 cells for transformatin of the lentiviral construct
- poor choice of titering cell line; use HT1080 cells or similar cell line
- Polybrene reagent is not included during transduction; transduce lentiviral construct into cells in the presence of Polybrene reagent
- Lipofectamine reagent handled incorrectly; ensure proper storage and mix gently before use
- Use fluorescence micrscopy to check titer with HiPerform FastTiter lentivirus

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

Citations & References (7)

Citations & References
Abstract
RIP140-targeted repression of gene expression in adipocytes.
Authors:Christian M, Kiskinis E, Debevec D, Leonardsson G, White R, Parker MG,
Journal:Mol Cell Biol
PubMed ID:16227589
'Ligand-dependent repression of nuclear receptor activity forms a novel mechanism for regulating gene expression. To investigate the intrinsic role of the corepressor RIP140, we have monitored gene expression profiles in cells that express or lack the RIP140 gene and that can be induced to undergo adipogenesis in vitro. In contrast ... More
Congenital Disorder of Glycosylation Id (CDG-Id) Presenting with Hyperinsulinemic Hypoglycemia and Islet Cell Hyperplasia.
Authors:Sun L, Eklund EA, Chung WK, Wang C, Cohen J, Freeze HH,
Journal:J Clin Endocrinol Metab
PubMed ID:15840742
'Context: Inborn errors in protein glycosylation such as the congenital disorders of glycosylation (CDG) generate multifaceted syndromes that impair many organ systems. We here report the diagnosis of the third known patient with CDG-Id. Results: The patient''s phenotype was extremely severe and she succumbed at nineteen days of age. Leading ... More
Group VIB Ca2+-independent Phospholipase A2{gamma} Promotes Cellular Membrane Hydrolysis and Prostaglandin Production in a Manner Distinct from Other Intracellular Phospholipases A2.
Authors:Murakami M, Masuda S, Ueda-Semmyo K, Yoda E, Kuwata H, Takanezawa Y, Aoki J, Arai H, Sumimoto H, Ishikawa Y, Ishii T, Nakatani Y, Kudo I,
Journal:J Biol Chem
PubMed ID:15695510
'Although group VIA Ca(2+)-independent phospholipase A(2)beta (iPLA(2)beta) has been implicated in various cellular events, the functions of other iPLA(2) isozymes remain largely elusive. In this study, we examined the cellular functions of group VIB iPLA(2)gamma. Lentiviral transfection of iPLA(2)gamma into HEK293 cells resulted in marked increases in spontaneous, stimulus-coupled, and ... More
A Novel Diacylglycerol-lactone Shows Marked Selectivity in Vitro among C1 Domains of Protein Kinase C (PKC) Isoforms {alpha} and {delta} as Well as Selectivity for RasGRP Compared with PKC{alpha}.
Authors:Pu Y, Perry NA, Yang D, Lewin NE, Kedei N, Braun DC, Choi SH, Blumberg PM, Garfield SH, Stone JC, Duan D, Marquez VE,
Journal:J Biol Chem
PubMed ID:15923197
'Although multiple natural products are potent ligands for the diacylglycerol binding C1 domain of protein kinase C (PKC), RasGRP, and related targets, the high conservation of C1 domains has impeded the development of selective ligands. We characterized here a diacylglycerol-lactone, 130C037, emerging from a combinatorial chemical synthetic strategy, which showed ... More
Methionine sulfoxide reductase A is important for lens cell viability and resistance to oxidative stress.
Authors:Kantorow M, Hawse JR, Cowell TL, Benhamed S, Pizarro GO, Reddy VN, Hejtmancik JF,
Journal:Proc Natl Acad Sci U S A
PubMed ID:15199188
Age-related cataract, an opacity of the eye lens, is the leading cause of visual impairment in the elderly, the etiology of which is related to oxidative stress damage. Oxidation of methionine to methionine sulfoxide is a major oxidative stress product that reaches levels as high as 60% in cataract while ... More